Zara C Bruce
Overview
Explore the profile of Zara C Bruce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
409
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Lim C, Dismuke T, Malawsky D, Oasa S, Bruce Z, et al.
Nat Commun
. 2025 Feb;
16(1):1091.
PMID: 39904981
OLIG2-expressing tumor stem cells have been shown to drive recurrence in Sonic Hedgehog (SHH)-subgroup medulloblastoma (MB) and patients urgently need specific therapies to target this tumor cell population. Here, we...
2.
Cullen J, Yap P, Ferguson B, Bruce Z, Koyama M, Handoko H, et al.
J Immunother Cancer
. 2024 Apr;
12(4).
PMID: 38658031
Background: Tigilanol tiglate (TT) is a protein kinase C (PKC)/C1 domain activator currently being developed as an intralesional agent for the treatment of various (sub)cutaneous malignancies. Previous work has shown...
3.
Li Y, Lim C, Dismuke T, Malawsky D, Oasa S, Bruce Z, et al.
Res Sq
. 2023 Jun;
PMID: 37333134
Recurrence is the primary life-threatening complication for medulloblastoma (MB). In Sonic Hedgehog (SHH)-subgroup MB, OLIG2-expressing tumor stem cells drive recurrence. We investigated the anti-tumor potential of the small-molecule OLIG2 inhibitor...
4.
Raju R, Cullen J, Bruce Z, Reddell P, Munch G
Fitoterapia
. 2021 Jun;
153:104972.
PMID: 34147546
A detailed phytochemical investigation of the leaves of the Australian rainforest tree Eupomatia laurina, led to the discovery of five new neolignans, eupomatenes A - E and eight known compounds,...
5.
Singh A, Cullen J, Bruce Z, Reddell P, Munch G, Raju R
Phytochemistry
. 2020 Jun;
176:112426.
PMID: 32505021
Chromatographic separation of the extracts of the Australian rainforest plant Ternstroemia cherryi led to the isolation of five undescribed barrigenol-like triterpenoids, ternstroenols A - E, from the fruits and three...
6.
Stringer B, Day B, DSouza R, Jamieson P, Ensbey K, Bruce Z, et al.
Sci Rep
. 2020 Jan;
10(1):1185.
PMID: 31965010
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
7.
Lim Y, Ensbey K, Offenhauser C, DSouza R, Cullen J, Stringer B, et al.
Neuro Oncol
. 2019 Sep;
22(2):216-228.
PMID: 31504812
Background: Despite significant endeavor having been applied to identify effective therapies to treat glioblastoma (GBM), survival outcomes remain intractable. The greatest nonsurgical benefit arises from radiotherapy, though tumors typically recur...
8.
Day B, Lathia J, Bruce Z, DSouza R, Baumgartner U, Ensbey K, et al.
Acta Neuropathol
. 2019 Aug;
138(6):1033-1052.
PMID: 31463571
Glioblastomas (GBMs) are malignant central nervous system (CNS) neoplasms with a very poor prognosis. They display cellular hierarchies containing self-renewing tumourigenic glioma stem cells (GSCs) in a complex heterogeneous microenvironment....
9.
Stringer B, Day B, DSouza R, Jamieson P, Ensbey K, Bruce Z, et al.
Sci Rep
. 2019 Mar;
9(1):4902.
PMID: 30894629
Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still...
10.
Offenhauser C, Al-Ejeh F, Puttick S, Ensbey K, Bruce Z, Jamieson P, et al.
Cancers (Basel)
. 2018 Dec;
10(12).
PMID: 30562956
The EphA3 receptor has recently emerged as a functional tumour-specific therapeutic target in glioblastoma (GBM). EphA3 is significantly elevated in recurrent disease, is most highly expressed on glioma stem cells...